Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blann

Showing results (211-220 of 420) with videos related to

Pageof 42
Sort By:
Thrombosis and Haemostasis|July 10, 1998
Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse eventsA D Blann, M Seigneur, M Steiner, et al.
Cancer Letters|August 8, 2006
Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancerGraham J Caine, Paul S Stonelake, Gregory Y H Lip, et al.
European Journal of Clinical Investigation|April 30, 2005
Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertensionH S Lim, G Y H Lip, D G Beevers, et al.
The American Journal of Cardiology|April 24, 1999
Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosisF L Li-Saw-Hee, A D Blann, I Goldsmith, et al.
The American Journal of Cardiology|May 18, 2001
Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrateA D Blann, F M Belgore, J Constans, et al.
European Heart Journal|August 21, 2001
Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial functionF L Li-Saw-Hee, A D Blann, D Gurney, et al.
The Prostate|May 11, 2011
Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: a comparison with plasma vascular markersAndrew D Blann, Balu Balakrishnan, Eduard Shantsila, et al.
Thrombosis Research|April 30, 2004
Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertensionSunil K Nadar, Eman Al Yemeni, Andrew D Blann, et al.
Journal of Clinical Pathology|March 3, 2004
Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteriesF Belgore, A Blann, D Neil, et al.
International Journal of Cardiology|June 9, 2007
Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunctionA D Blann, A Choudhury, B Freestone, et al.
Pageof 42

Showing results (211-220 of 420) with videos related to

Sort By:
Pageof 42
Thrombosis and Haemostasis|July 10, 1998
Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse eventsA D Blann, M Seigneur, M Steiner, et al.
Cancer Letters|August 8, 2006
Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancerGraham J Caine, Paul S Stonelake, Gregory Y H Lip, et al.
European Journal of Clinical Investigation|April 30, 2005
Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertensionH S Lim, G Y H Lip, D G Beevers, et al.
The American Journal of Cardiology|April 24, 1999
Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosisF L Li-Saw-Hee, A D Blann, I Goldsmith, et al.
The American Journal of Cardiology|May 18, 2001
Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrateA D Blann, F M Belgore, J Constans, et al.
European Heart Journal|August 21, 2001
Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial functionF L Li-Saw-Hee, A D Blann, D Gurney, et al.
The Prostate|May 11, 2011
Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: a comparison with plasma vascular markersAndrew D Blann, Balu Balakrishnan, Eduard Shantsila, et al.
Thrombosis Research|April 30, 2004
Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertensionSunil K Nadar, Eman Al Yemeni, Andrew D Blann, et al.
Journal of Clinical Pathology|March 3, 2004
Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteriesF Belgore, A Blann, D Neil, et al.
International Journal of Cardiology|June 9, 2007
Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunctionA D Blann, A Choudhury, B Freestone, et al.
Pageof 42